Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight

Mar.04.2025
Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
MASKKING introduces innovative e-cigarette with built-in flashlight, appealing to outdoor enthusiasts and tech lovers. (18 words)

Special declaration:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are solely for the purpose of depicting facts and are not intended as advertisements for any products.

Minors are prohibited from accessing this article.


 

2Firsts observed that e-cigarette brand MASKKING recently released a new model e-cigarette - the Maskking Moonlight 10000. This product combines the design of an e-cigarette with a flashlight, and also features a replaceable drip tip.

 

Specifically, the product specifications of Maskking Moonlight 10000 are shown in the table below.

 

Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
Maskking Moonlight 10000 Product Parameters | Illustration: 2FIRSTS
Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
Mankosway Company Introduction | Image Source: Boss Zhipin

 

In terms of product features, the biggest selling point of Maskking Moonlight 10000 lies in its design featuring a built-in flashlight. The e-cigarette website vape.hk states that this design is particularly suitable for "nomads, outdoor sports enthusiasts, and tech enthusiasts" to use.

 

Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
Maskking Moonlight 10000 Product Introduction | Image Source: vape.hk.

 

However, the Maskking Moonlight 10000 e-cigarette only has a capacity of 650mAH, which is lower compared to other e-cigarette products on the market. This may make it difficult to simultaneously use the e-cigarette and flashlight functions.

 

Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
Translation: Maskking Moonlight 10000 | Image source: MASKKING

 

In addition, Maskking Moonlight 10000 is equipped with replaceable mouthpieces that can meet users' needs for smoke volume and taste by using different drip tip diameters.

 

On the manufacturer side, information on the official website of the MASKKING brand indicates that the brand is owned by Mankosway (Shenzhen) Technology Co., Ltd., located in Baoan District, Shenzhen. The company was established in 2018.

 

Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
Mankosway (Shenzhen) Technology Co., Ltd. | Image source: QCC

 

According to the trademark search system of Alibaba Cloud, two "MASKKING" tobacco smoking device trademarks were registered by Beijing Mankesway Technology Development Co., Ltd. in July 2019 and January 2021, respectively.

 

Maskking Moonlight 10000: A Unique Combination of E-cigarette and Flashlight
MASKKING" trademark information | Image source: Alibaba Cloud trademark search.

According to the company introduction posted on Boss Zhipin, the headquarters of Maskking was established in Beijing, China, the market operations center is located in Shenzhen, Guangdong Province, China, and the independent factory is located in Dongguan City. It is an original brand manufacturer (OBM) engaged in research and development, production, and sales services.

 

Currently, the Maskking Moonlight 10000 e-cigarette has been listed on the official MASKKING brand website and social media accounts, but the product is not yet available for sale on overseas e-cigarette distributor websites.

 

The product column of 2FIRSTS is dedicated to providing readers with the latest information on new products in the tobacco industry. We welcome readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, feel free to contact us anytime through email at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris and BAT’s Nicoventures Win EPO Appeal to Revoke VMR Vape Patent
Philip Morris and BAT’s Nicoventures Win EPO Appeal to Revoke VMR Vape Patent
The EPO Technical Board of Appeal 3.2.02 (T 1319/24) revoked VMR Products LLC’s EP3613453 “VAPORIZER” patent after finding that a 2012 YouTube video of the Innokin iTaste VV (D3) disclosed the claimed electrical contact arrangement. Opponents Nicoventures Trading Ltd (BAT subsidiary) and Philip Morris Products S.A. prevailed.
BATPMI
Feb.17
Turning Point Brands Reports Strong Fourth-Quarter Performance for Fiscal Year 2025: Revenue up 29%, Modern Oral Segment Sees 266% Growth; Company Issues 2026 Guidance for Sales and EBITDA.
Turning Point Brands Reports Strong Fourth-Quarter Performance for Fiscal Year 2025: Revenue up 29%, Modern Oral Segment Sees 266% Growth; Company Issues 2026 Guidance for Sales and EBITDA.
Turning Point Brands reports 29% revenue increase in Q4 2025, with Modern Oral net sales up 266%.2026 guidance provided.
Mar.03 by 2FIRSTS.ai
Russia proposes extending voluntary labeling pilot for reusable e-cigarettes to Aug. 31, 2026
Russia proposes extending voluntary labeling pilot for reusable e-cigarettes to Aug. 31, 2026
Russia’s Ministry of Industry and Trade has proposed extending a voluntary labeling pilot covering reusable e-cigarettes and similar personal electric vaporizing devices until August 31, 2026. A draft government decree has been published on the unified portal for posting drafts of normative legal acts.
Jan.22 by 2FIRSTS.ai
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan has approved amendments to its tobacco law that introduce a comprehensive ban on e-cigarettes and their components, covering import, export, production, storage, wholesale and retail sales, and use. Nicotine-containing e-cigarettes are classified as tobacco products under the revised framework. The law takes effect on April 1, 2026.
Jan.27 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
Make Your Brand Understood by the People Who Matter
Make Your Brand Understood by the People Who Matter
Feb.02